Introduction: Women with gestational diabetes mellitus (GDM) often deliver newborns large for their gestational age (LGA). The aim of the study was to evaluate the effect of lipid parameters in the second half of pregnancy on foetal growth in GDM pregnancies. Material and methods: In two hundred consecutive women with GDM the age, body mass index before pregnancy, body mass index before delivery, gestational week of GDM diagnosis, lipid parameters after 24 weeks of pregnancy, fasting glycaemia, HbA1c in the second and third trimester of pregnancy, gestational age at delivery, mode of delivery, and baby birth weight were analyzed. Results: Of the 200 GDM pregnancies, 50 (25%) women delivered LGA newborns, 135 (67.5%) women delivered newborns appropriate for gestational age (AGA), and 15 (7.5%) women delivered newborns small for gestational age (SGA). Maternal triglyceride levels and HbA1c in the second trimester were higher, and HDL-C was significantly lower, in the LGA group than in the AGA group (3.8 ± 1.8 vs. 3.1 ± 1.1 mmol/L, 6.1 ± 1.1 vs. 5.5 ± 0.8%, and 1.3 ± 0.4 vs. 1.6 ± 0.4 mmol/L, p < 0.05). Also, maternal triglyceride levels and HbA1c in the second trimester were significantly higher in the SGA group than in the AGA group (3.8 ± 1.9 vs. 3.1 ± 1.1 mmol/L and 6.8 ± 0.8 vs. 5.5 ± 0.8%, p < 0.05). Maternal triglycerides were independent predictors for delivering LGA newborns in GDM women. Conclusion: In GDM pregnancies, maternal triglycerides in the second half of pregnancy may indentify women who will deliver LGA newborns. Thus, with good regulation of lipid profile, we can avoid macrosomia from GDM pregnancies.
Introduction
Maternal lipid metabolism is altered during pregnancy with increased tissue lipolysis and associated hyperlipidaemia [1, 2] . Hyperlipidaemia is common in the second half of pregnancy as a physiologically required mechanism to maintain stable fuel supplementation to the foetus [3] . In normal pregnancy, as the pregnancy progresses, there is evidence of reference values for lipids according to gestational weeks [4] .
It is known that women with gestational diabetes mellitus (GDM) often deliver newborns large for their gestational age (LGA). This is due to maternal hyperglycaemia, but there is evidence that not only glucose but also disturbance in the maternal lipid metabolism may contribute to foetal overgrowth [5] .
Variation of birth weight is strongly determined by neonatal fat mass, and it is likely that foetal growth disorders might also result from variations in maternal and foetal lipid metabolism. In nondiabetic pregnancies, maternal triglycerides have been shown to be correlated with birth weight [4, [6] [7] [8] .
The aim of the study was to evaluate the effect of lipid parameters in the second half of pregnancy on foetal growth in GDM pregnancies.
Material and methods
Two hundred consecutive women with GDM who visited the Outpatient Department of the University Endocrinology, Diabetes and Metabolic Disorders Clinic were analysed. All were with singleton pregnancies, and the neonates were delivered at the University Gynaecology and Obstetrics Clinic. The criteria for GDM were at least one out of three abnormally high plasma glucose value measurements during the 2-hour 75 g. oral glucose tolerance test (OGTT) (normal values: fasting level < 5.1, 1-h level < 10.0, 2-h level < 8.5 mmol/L). Venous blood glucose levels were measured by glucose oxidase (Glucose Analyzer; Beckman, Brea, CA).
In the second half of pregnancy maternal fasting serum triglycerides, total cholesterol (TCh), high-density lipoprotein (HDL-C), and low-density lipoprotein cholesterol (LDL-C) levels were determined. Maternal HbA1c in the second and third trimester of pregnancy were measured. The BMI of women with GDM was calculated by dividing the weight by the height squared (kilograms/metres 2 ). Pre-pregnancy body mass index (BMI 1) was calculated from selfreported pre-pregnancy height and weight. Predelivery body mass index (BMI 2) was measured on delivery admission day in the University Gynecology and Obstetrics Clinic. The gestational age was estimated from the date of the last menstrual period (all patients had regular menstrual cycles). The babies' birth weights were classified as LGA, appropriate for gestational age (AGA), and small for gestational age (SGA). We defined LGA as a birth weight above the 90th percentile, SGA as a birth weight below the 10th percentile for gestational age and AGA between the two.
Blood samples for HbA1c and lipid assessment were taken after overnight fasting. The blood samples for lipoproteins were analyzed using Cobas Integra 700, according to standard methods. TCh and triglycerides were determined by full enzymatic methods (TCh-CHOD-POD-PAP and triglycerides-GPO; Cobas Integra 700, Hoffmann-La Roche, Basel, Switzerland). HDL-C was measured by the polyanion precipitation method, while LDL-C was calculated using the Friedewald formula. LDL-C were fractioned using ultracentrifugation in cases of triglycerides exceeding 4mmol/l. HbA1c was measured by an ionexchange HPL-C instrument (DS5; Drew, USA) with a reference range of 4.2-6%.
The study was carried out according to the Declaration of Helsinki.
Statistical analyses were performed using SPSS software for Windows, version 14.0. For analysis, t-test, Chi-square test, correlation, and linear multiple regression were used. p < 0.05 was considered statistically significant.
Results
Of the 200 GDM pregnancies, 50 (25%) women delivered LGA newborns, 135 (67.5%) women delivered appropriate for gestational age (AGA) newborns, and 15 (7.5%) women delivered small for gestational age (SGA) newborns. The characteristics among women who delivered LGA, AGA, and SGA newborns are shown in Table1.
Maternal BMI 1 and BMI 2 were signifycantly higher in the LGA group than in the AGA and SGA groups (28.4 ± 6.1 vs. 26.5 ± 4.9, 28.4 ± 6.1 vs. 25.0 ± 4.6, and 33.1 ± 6.1 vs. 31.1 ± 4.9, 33.1 ± 6.1 vs. 29.3 ± 4.4 kg/m 2 , respectively, p < 0.05). Maternal triglyceride levels and HbA1c in the second trimester were significantly higher, and HDL-C was significantly lower in the LGA and SGA groups than in the AGA group (Table 1, p < 0.05). The percentage of cаesarean section in the SGA group was significantly lower than in the LGA and AGA groups, but it was not different between LGA and AGA groups. Gestational weeks of delivery were lower in the SGA group, and higher in the LGA group. Given data are means ± SD, t-test was used *given data are percentages, chi-square was used
Maternal triglycerides statistically significantly correlated with BMI 1 and HbA1c in the second trimester (r = 0.25, p=0.07 and r = 0.31, p = 0.04). No significant correlation was found between maternal triglycerides and baby birth weight (r = 0.16, p = 0.077), but p value was close to statistical significance. Baby birth weight correlated statistically significantly with HbA1c in the second trimester (r = 0.30, p = 0.04).
Univariant analysis showed a statistical significance between baby birth weight and BMI 1, BMI 2, HbA1c in the second trimester, HDL-C and triglycerides.
To determine independent predictors of LGA we used linear multiple regression analysis with LGA as a dependent variable. Analysis (Table 2) showed that triglycerides were independent predictors for delivering LGA newborns in GDM women. 
Discussion
The results of the study showed that triglycerides in the second half of pregnancy and HbA1c in the second trimester were significant risk factors for delivering LGA newborns in GDM pregnancies.
It is known that maternal obesity is a major risk factor for LGA newborns especially in GDM pregnancies [9] [10] [11] . Our results confirm this. Women who delivered LGA newborns had a higher BMI 1 and BMI 2. But later triglyceride levels were shown as predictors for LGA, independently of BMI.
Our findings are in accordance with those of Kitijama et al. and Knopp et al. [4, 6] , who showed that high maternal triglyceride levels predicted macrosomia independently of maternal BMI. Schaefer-Graf et al. [12] demonstrated that maternal lipids were strong determinants of foetal growth in pregnant women with GDM. In arterial cord blood serum they found higher free fatty acids levels in women with GDM. Our study confirms that triglycerides were significantly higher and an independent predictor for LGA in GDM pregnancies. They can predict LGA newborns independently of maternal BMI 1, BMI 2, and HbA1c in the second trimester of pregnancy. These results suggest including lifestyle programmes for women of reproductive age with a focus on lowering triglyceride levels: diet, weight reduction, and physical activity. Routine measurement of maternal serum triglyceride levels at the beginning of the second half of pregnancy may show women who have acquired an adequate and balanced diet.
A statistically significant positive correlation between triglycerides and baby birth weight was not found, but p value (p = 0.07) was very close to significance. Maybe in a larger population this correlation will be statistically significant.
The mechanism by which pregnancy alters lipid metabolism is not fully understood. Oestrogens can increase levels of triglycerides by stimulating hepatic production of very low density lipoproteins and by inhibition of hepatic and adipose tissue lipoprotein lipase. Progesterone has the opposite action on lipoprotein metabolism. It has therefore been suggested that the oestrogen-progesterone ratio is higher in the second half of pregnancy and that explains the higher triglyceride levels as pregnancy progresses. Triglyceride clearance is reduced due to decreased lipoprotein lipase activity [3] . These changes coincide with reduced insulin sensitivity, which may also contribute to the increase in triglycerides. Because maternal triglyceride does not cross the placenta, enhanced insulin resistance in GDM pregnancies may explain the relationship between maternal triglyceride levels and foetal growth [13] . The statistically significant correlation between triglycerides and BMI 1, and between triglycerides and HbA1c in the second trimester, can be explained by decreased insulin sensitivity, which is already known and has been shown in previous studies in women with GDM.
Surprisingly, only HbA1c in the second trimester, not in the third trimester, was statistically significantly higher in the LGA and SGA groups than in the AGA group. HbA1c in the third trimester was also higher in the LGA and SGA groups than in the AGA group, but without statistical significance. Maybe good glycaemic control in the third trimester of pregnancy is responsible for lowering the HbA1c in the LGA and SGA groups.
Triglyceride levels in the SGA group were statistically significantly higher than in the AGA group. This cannot be explained by BMI, because these groups were not significantly different in BMI 1 or BMI 2. SchaeferGraf UM et al. [12] also found significantly higher triglycerides in SGA newborns compared with AGA or LGA newborns. They explain these results by endothelial dysfunction in the placenta. Endothelial dysfunction in the placenta is reported to be associated with maternal complications and newborns' growth retardation. Increasing evidence suggests that elevated plasma lipids, including triglycerides or their related remnants, may induce endothelial dysfunction [14] . Increased peroxidation of these elevated plasma lipids causes enhanced oxidative stress by progressively producing free radicals and lipid peroxides. Lipid peroxides are toxic compounds that have the potential to damage endothelial cells [15] .
Catov et al. [16] showed that high cholesterol or triglycerides before the 15 gestational weeks were associated with a 2.0-fold increased risk for preterm birth. They propose maternal hyperlipidaemia could increase the oxidative stress in the foetus resulting not only in vessel wall damage, but also in disruption of normal placentation. Infection and inflammation induce the acute-phase response, leading to multiple alterations in lipid and lipoprotein metabolism, especially hypertriglyceridaemia [17] . So, inflammation, subclinical infection, and some metabolic factors such as hypertriglyceridaemia and obesity in pregnancy are associated with preterm birth risk. This could be the explanation for higher triglycerides, HDL-C, and early delivery in women with GDM which deliver SGA newborns. Maybe the effect on the placenta is different in different periods of pregnancy. In early pregnancy triglycerides affect vascular development and in late pregnancy they have a direct harmful effect on the endothelium of placental vasculature. But we did not analyse lipid parameters in different periods of pregnancy to confirm this.
Excessive mother to foetus glucose transfer increases not only the risk of large, but also the risk of small for gestational age newborns [18] . In our study women who delivered SGA newborns had a statistically significant higher HbA1c in the second trimester in comparison with AGA. Thus GDM increases the risk of LGA and also the risk of SGA newborns.
Time of delivery was significantly differrent in the three study groups, but all were in term. Surprisingly, LGA were delivered in normal term, but statistically significantly later than AGA.
We were not able to explain the higher percentage of section cesarean in the AGA group. Maybe the fact of existing GDM was responsible for the high percentage.
Additional studies which compare the lipid parameters in different pregnancy periods and their contribution to foetal growth are needed to give true answers.
Conclusion
In GDM pregnancies, maternal triglycerides in the second half of pregnancy may indentify women who will deliver LGA newborns. Thus, with a good regulation of lipid profile we can avoid macrosomia in GDM pregnancies.
